High-Speed Chronoamperometry to Study Kinetics and Mechanisms for Serotonin Clearance In Vivo
- PMID: 21204384
- Bookshelf ID: NBK2570
High-Speed Chronoamperometry to Study Kinetics and Mechanisms for Serotonin Clearance In Vivo
Excerpt
Serotonin (5-HT) regulates many complex behaviors and physiological functions. These include mood, sleep, feeding and thermoregulation, to name but a few. As a result, dysregulation of 5-HT neurotransmission can have severe consequences. For example, reduced serotonin neurotransmission is thought to underlie such affective disorders as depression and anxiety (Owens and Nemeroff 1994; Nemeroff and Owens 2004) and predispose to addictive disorders such as alcoholism (McBride et al. 1993; Virkkunen and Linnoila 1997). In addition, the hyperserotonergic state resulting from high doses of substituted amphetamines such as 3,4- methylenedioxymethamphetamine (MDMA, “Ecstasy”) contributes to the “serotonin syndrome,” symptoms of which include agitation, high body temperature, tachycardia, convulsions, coma, and in some cases death (Hegadoren et al. 1999; Green et al. 2003). Given the clear importance of maintaining homeostatic 5-HT neurotransmission, the regulation of extracellular concentration of 5-HT has been the focus of intense study for the past several decades.
The principle mechanism for terminating the neurochemical actions of 5-HT released from nerve terminals is its high affinity uptake from extracellular fluid by the serotonin transporter (5-HTT; SERT). Consequently, since this transporter was first identified in the brain (Shaskan and Snyder 1970; Kuhar et al. 1972), it has been studied extensively (Fuller and Wong 1990; Blakely et al. 1991; Rudnick and Wall 1993; Bengel et al. 1998; Blakely et al. 1998; Kilic et al. 2003). Until relatively recently, active uptake of 5-HT by its transporter has been studied using in vitro techniques such as [3H]5-HT uptake into brain synaptosomes (Shaskan and Snyder 1970; Kokoshka et al. 1998) or into cells transfected with the 5-HTT (Wall et al. 1995; Ramamoorthy and Blakely 1999; Zhu et al. 2005). However, modern voltammetric technologies that stemmed from the pioneering work of Ralph Adams in the 1970s (Kissinger et al. 1973) have allowed 5-HTT function to be measured in vivo. Herein we describe applications of high-speed chronoamperometry, an amperometric technique, to study 5-HTT function in vivo as well as to identify alternative mechanisms for 5-HT clearance from extracellular fluid.
Copyright © 2007, Taylor & Francis Group, LLC.
Sections
Similar articles
-
In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.J Neurochem. 2007 Feb;100(3):617-27. doi: 10.1111/j.1471-4159.2006.04247.x. Epub 2006 Dec 1. J Neurochem. 2007. PMID: 17181558
-
Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry.Neurochem Int. 2005 Oct;47(5):350-61. doi: 10.1016/j.neuint.2005.04.026. Neurochem Int. 2005. PMID: 15979209
-
Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter (SERT).Neuropsychopharmacology. 1998 Oct;19(4):265-77. doi: 10.1016/S0893-133X(98)00027-X. Neuropsychopharmacology. 1998. PMID: 9718590
-
Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners.J Neural Transm (Vienna). 1997;104(8-9):771-94. doi: 10.1007/BF01285547. J Neural Transm (Vienna). 1997. PMID: 9451711 Review.
-
Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from in vitro and animal-based studies.J Musculoskelet Neuronal Interact. 2008 Apr-Jun;8(2):121-32. J Musculoskelet Neuronal Interact. 2008. PMID: 18622081 Free PMC article. Review.
References
-
- Ansah TA, Ramamoorthy S, Montanez S, Daws LC, Blakely RD. Calcium-dependent inhibition of synaptosomal serotonin transport by the α 2-adrenoceptor agonist 5-bromo-N-[4,5-dihydro-1Himidazol- 2-yl]-6-quinoxalinamine (UK14304) J Pharmacol Exp Ther. 2003;305:956–965. - PubMed
-
- Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mossner R, Westphal H, Lesch KP. Altered brain serotonin (5-HT) homeostasis and locomotor insensitivity to MDMA (“ecstasy”) in 5-HT transporter deficient mice. Mol Pharmacol. 1998;53:649–655. - PubMed
-
- Blakely RD, Bauman AL. Biogenic amine transporters: regulation in flux. Curr Opin Neurobiol. 2000;10:328–336. - PubMed
-
- Blakely RD, Berson HE, Fremeau RT, Jr, Caron MG, Peek MM, Prince HK, Bradley CC. Cloning and expression of a functional serotonin transporter from rat brain. Nature. 1991;354:66–70. - PubMed
-
- Blakely RD, Ramamoorthy S, Schroeter S, Qian Y, Apparsundaram S, Galli A, DeFelice LJ. Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol Psychiatry. 1998;44:169–178. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous